Literature DB >> 621526

Non-invasive regional study of chronic cerebrovascular disorders using the oxygen-15 inhalation technique.

G L Lenzi, T Jones, C G McKenzie, S Moss.   

Abstract

The regional cerebral metabolism-to-perfusion imbalance has been studied in the three main categories of cerebrovascular disorders in a chronic phase of the disease, using the non-invasive oxygen-15 inhalation technique. In patients presenting with a history of transient ischaemic attacks, regional defects in cerebral perfusion were greater than for the corresponding oxygen uptakes. Areas of relative ischaemia within which there was an enforced increase in the oxygen extraction ratio were highlighted. The reverse pattern was observed frequently in patients with brain infarcts arising from strokes, so indicating areas of relative luxury perfusion as is inferred from the reduction in the oxygen extraction ratio. In the multi-infarct dementia group of patients, there were parallel focal reductions in both flow and metabolism. The oxygen-15 inhalation technique is shown to be a unique tool in investigating cerebrovascular disorders because of its non-invasiveness and its ability to define regional metabolism-to-perfusion imbalance within the brain.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 621526      PMCID: PMC492956          DOI: 10.1136/jnnp.41.1.11

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

2.  Mental function and cerebral oxygen consumption in organic dementia.

Authors:  N A LASSEN; O MUNCK; E R TOTTEY
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-02

3.  The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localised within the brain.

Authors:  N A Lassen
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

4.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

5.  Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery.

Authors:  O B Paulson
Journal:  Neurology       Date:  1970-01       Impact factor: 9.910

6.  Regional cerebral blood flow and its autoregulation in patients with transient focal cerebral ischemic attacks.

Authors:  E Skinhoj; K Hoedt-Rasmussen; O B Paulson; N A Lassen
Journal:  Neurology       Date:  1970-05       Impact factor: 9.910

7.  Regional cerebral blood flow and its regulation in dementia.

Authors:  D Simard; J Olesen; O B Paulson; N A Lassen; E Skinhoj
Journal:  Brain       Date:  1971       Impact factor: 13.501

8.  The continuous inhalation of oxygen-15 for assessing regional oxygen extraction in the brain of man.

Authors:  T Jones; D A Chesler; M M Ter-Pogossian
Journal:  Br J Radiol       Date:  1976-04       Impact factor: 3.039

9.  Study of regional cerebral metabolism and blood flow relationships in man using the method of continuously inhaling oxygen-15 and oxygen-15 labelled carbon dioxide.

Authors:  G L Lenzi; T Jones; C G McKenzie; P D Buckingham; J C Clark; S Moss
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-01       Impact factor: 10.154

  9 in total
  3 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Regional impairment of cerebral oxidative metabolism in Parkinson's disease.

Authors:  G L Lenzi; T Jones; J L Reid; S Moss
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-01       Impact factor: 10.154

3.  Radioactive oxygen 15O studies in cerebral neoplasms.

Authors:  C G McKenzie; G L Lenzi; T Jones; S Moss
Journal:  J R Soc Med       Date:  1978-06       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.